Wordt geladen...
Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2
To date, no vaccines or effective drugs have been approved to prevent or treat COVID-19 and the current standard care relies on supportive treatments. Therefore, based on the fast and global spread of the virus, urgent investigations are warranted in order to develop preventive and therapeutic drugs...
Bewaard in:
| Gepubliceerd in: | Signal Transduct Target Ther |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Nature Publishing Group UK
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7255975/ https://ncbi.nlm.nih.gov/pubmed/32467561 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41392-020-0191-1 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|